Literature DB >> 9685283

Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology.

Z E Hopkinson1, N Sattar, R Fleming, I A Greer.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9685283      PMCID： PMC1113632          DOI： 10.1136/bmj.317.7154.329

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  30 in total

1.  Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.

Authors:  E Velázquez; A Acosta; S G Mendoza
Journal:  Obstet Gynecol       Date:  1997-09       Impact factor: 7.661

Review 2.  Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.

Authors:  J P Després; S Moorjani; P J Lupien; A Tremblay; A Nadeau; C Bouchard
Journal:  Arteriosclerosis       Date:  1990 Jul-Aug

3.  Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.

Authors:  D A Ehrmann; D J Schneider; B E Sobel; M K Cavaghan; J Imperial; R L Rosenfield; K S Polonsky
Journal:  J Clin Endocrinol Metab       Date:  1997-07       Impact factor: 5.958

Review 4.  Insulin-like growth factor binding proteins: do they play a role in polycystic ovary syndrome?

Authors:  N A Cataldo
Journal:  Semin Reprod Endocrinol       Date:  1997-05

Review 5.  Adrenal involvement in polycystic ovary syndrome.

Authors:  F Gonzalez
Journal:  Semin Reprod Endocrinol       Date:  1997-05

Review 6.  Insulin regulation of human ovarian androgens.

Authors:  J E Nestler
Journal:  Hum Reprod       Date:  1997-10       Impact factor: 6.918

Review 7.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

Authors:  A Dunaif
Journal:  Endocr Rev       Date:  1997-12       Impact factor: 19.871

8.  Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens.

Authors:  J E Nestler; D J Jakubowicz
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

9.  Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.

Authors:  G S Conway; R Agrawal; D J Betteridge; H S Jacobs
Journal:  Clin Endocrinol (Oxf)       Date:  1992-08       Impact factor: 3.478

10.  Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones.

Authors:  E Dahlgren; S Johansson; G Lindstedt; F Knutsson; A Odén; P O Janson; L A Mattson; N Crona; P A Lundberg
Journal:  Fertil Steril       Date:  1992-03       Impact factor: 7.329
View more
  15 in total

1.  HIV protease inhibitors, the lipodystrophy syndrome and polycystic ovary syndrome--is there a link?

Authors:  J D Wilson; R J Dunham; A H Balen
Journal:  Sex Transm Infect       Date:  1999-08       Impact factor: 3.519

2.  Bulimic eating patterns should be stabilised in polycystic ovarian syndrome.

Authors:  J F Morgan
Journal:  BMJ       Date:  1999-01-30

3.  Nesfatin-1 and other hormone alterations in polycystic ovary syndrome.

Authors:  Rulin Deniz; Bilgin Gurates; Suleyman Aydin; Husnu Celik; Ibrahim Sahin; Yakup Baykus; Zekiye Catak; Aziz Aksoy; Cihan Citil; Sami Gungor
Journal:  Endocrine       Date:  2012-02-25       Impact factor: 3.633

4.  Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women.

Authors:  Melissa E Weinberg; JoAnn E Manson; Julie E Buring; Nancy R Cook; Ellen W Seely; Paul M Ridker; Kathryn M Rexrode
Journal:  Metabolism       Date:  2006-11       Impact factor: 8.694

Review 5.  Insulin resistance, polycystic ovary syndrome and metformin.

Authors:  M Pugeat; P H Ducluzeau
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 6.  Progestogens with antiandrogenic properties.

Authors:  Daniel Raudrant; Thomas Rabe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Total and lipid bound sialic acid levels in patients with polycystic ovary syndrome.

Authors:  Ali Ozcan; Aykan Yücel; Volkan Noyan; Nevin Sağsöz; Osman Cağlayan
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-06-01

8.  Sensitive and specific markers for insulin resistance, hyperandrogenemia, and inappropriate gonadotrophin secretion in women with polycystic ovary syndrome: a case-control study from Bahrain.

Authors:  Jamal Golbahar; Maha Al-Ayadhi; Negalla Mohan Das; Khalid Gumaa
Journal:  Int J Womens Health       Date:  2012-05-11

9.  Weight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks.

Authors:  Efsevia A Nikokavoura; Kelly L Johnston; John Broom; Wendy L Wrieden; Catherine Rolland
Journal:  Diabetes Metab Syndr Obes       Date:  2015-10-14       Impact factor: 3.168

10.  The experiences of women with polycystic ovary syndrome on a very low-calorie diet.

Authors:  John G Love; John S McKenzie; Efsevia A Nikokavoura; John Broom; Catherine Rolland; Kelly L Johnston
Journal:  Int J Womens Health       Date:  2016-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.